Cost-effectiveness analysis of commercial Chinese polyherbal preparations for primary insomnia: based on network meta-analysis.

ABSTRACT:

Objectives

Building upon prior systematic reviews and network meta-analyses, this study evaluated the cost-effectiveness of four commercial Chinese polyherbal preparations (CCPPs)-Tian Meng Oral Liquid/Capsules (TM), Shen-Qi-Wu-Wei-Zi Tablets (SQWWZ), Wu Ling Capsules (WL), and Bai-Le-Mian Capsules (BLM)-for treating primary insomnia. Comparative findings informed clinical decision-making and health policy formulation.

Methods

A cost-effectiveness analysis was conducted from a healthcare system perspective. A patient disease course model was developed using systematic literature search and network meta-analysis combined with drug pricing data. Intervention strategies (monotherapy or combination therapy) were simulated to assess per-capita costs and health outcomes. Increment

SUBMITTER: Yang S 

PROVIDER: S-EPMC12722917 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature